Brazil Approval for Sanofi's Dengue Vaccine

Published on: 

January 07, 2016.

Brazil has approved Sanofi Pasteur’s new dengue vaccine Dengvaxia as a preventive tool.


Brazil's regulator ANVISA approved the vaccine to prevent all four types of dengue in people ages 9 to 45 in regions where the tropical disease is present. More than 1.4 million Brazilians were infected with the virus this outbreak season,.